z-logo
Premium
n‐Butyrate Anergized Effector CD4 + T Cells Independent of Regulatory T cell Generation or Activity
Author(s) -
Fontenelle B.,
Gilbert K. M.
Publication year - 2012
Publication title -
scandinavian journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.934
H-Index - 88
eISSN - 1365-3083
pISSN - 0300-9475
DOI - 10.1111/j.1365-3083.2012.02740.x
Subject(s) - butyrate , foxp3 , t cell , microbiology and biotechnology , cytotoxic t cell , histone deacetylase , biology , secretion , interleukin 21 , chemistry , immunology , in vitro , immune system , histone , biochemistry , fermentation , gene
CD4 + T cell anergy reflects the inability of CD4 + T cells to respond functionally to antigenic stimulation through proliferation or IL‐2 secretion. Histone deacetylase (HDAC) inhibitors have been shown to induce anergy in antigen‐activated CD4 + T cells. However, questions remain if HDAC inhibitors mediate anergy through direct action upon activated CD4 + T cells or through the generation and/or enhancement of regulatory T (T reg ) cells. To assess if HDAC inhibitor n‐butyrate induces anergy independent of the generation or expansion of FoxP3 + T reg cells in vitro , we examine n‐butyrate‐treated murine CD4 + T cells for anergy induction and FoxP3 + T reg activity. Whereas n‐butyrate decreases CD4 + T cell proliferation and IL‐2 secretion, n‐butyrate did not augment FoxP3 protein production or confer a suppressive phenotype upon CD4 + T cells. Collectively, these data suggest that HDAC inhibitors can facilitate CD4 + T cell functional unresponsiveness directly and independently of T reg cell involvement.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom